Search BDX
BECTON DICKINSON & CO
NYSE · CIK 10795
Last close176.8
Daily change-1.27 (-0.71%)
10 Years gain+45.41%
Dividends TTM3.8 (+47.76%)
Dividend yield2.13%
Fundamental Analysis
BDX · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 0930
Fundamental
41.2Momentum
46.8Acceleration
46.5Confidence
91.0Annual Revenue19
Quarterly Revenue74
Annual CFO8
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth4.1 / 25
Quality15.4 / 25
Capital Efficiency5.6 / 20
Balance Sheet4.9 / 15
Shareholder Economics9.2 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 2.0917 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 4.3717%.
Key Metrics
Revenue Growth TTM-0.04%OK
Revenue CAGR 3Y4.99%OK
Gross Margin46.33%OK
Operating Margin10.4%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC3.89%OK
Incremental Operating Margin 3Y-14.29%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-4.37%OK
SBC / Revenue1.28%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Sep 30, 2025 | $21.84B | $9.93B | $2.58B | n/a | n/a | 45.44% | 11.81% | n/a | 5.22% | 288.51M |
| 2025 FY Sep 30, 2024 | $20.18B | $9.13B | $2.40B | n/a | n/a | 45.22% | 11.88% | n/a | 4.82% | 291.01M |
| 2025 FY Sep 30, 2023 | $19.37B | $8.17B | $2.11B | n/a | n/a | 42.17% | 10.9% | n/a | 4.82% | 288.39M |
| 2024 FY Sep 30, 2022 | $18.87B | $8.48B | $2.28B | n/a | n/a | 44.92% | 12.09% | n/a | 5.27% | 287.36M |
| 2023 FY Sep 30, 2021 | $19.13B | $8.63B | $2.25B | n/a | n/a | 45.12% | 11.76% | n/a | 5.48% | 292.09M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $19.68B | sum latest 4 fiscal quarters Revenue | OK | 0000010795-26-000035, 0000010795-26-000005 |
| Revenue Growth TTM | -0.04% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000010795-26-000035, 0000010795-26-000005 |
| Revenue CAGR 3Y | 4.99% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000010795-25-000099 |
| Revenue CAGR 5Y | 6.32% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000010795-25-000099 |
| Gross Profit CAGR 3Y | 5.4% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000010795-25-000099 |
| Operating Income Growth | -5.76% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000010795-26-000035, 0000010795-26-000005 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 46.33% | Gross Profit / Revenue | OK | 0000010795-26-000035, 0000010795-26-000005 |
| Operating Margin | 10.4% | Operating Income / Revenue | OK | 0000010795-26-000035, 0000010795-26-000005 |
| ROIC | 3.89% | NOPAT / Average Invested Capital | OK | 0000010795-26-000035, 0000010795-26-000005 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000010795-26-000035 |
| Current Ratio | 0.87x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.04x | (Cash + Short-term Investments) / Total Debt | OK | 0000010795-26-000035 |
| SBC / Revenue | 1.28% | SBC / Revenue | OK | 0000010795-26-000035, 0000010795-26-000026 |